Hypoxia — a Leading Factor of Chronic Kidney Disease Progression
Journal Title: Нирки - Year 2016, Vol 1, Issue 15
Abstract
Recent data indicate the involvement of hypoxia in the formation of kidney fibrosis and progression of chronic renal disease. One of the main factors in the chain of damage in the tissue oxygen deficiency is a hypoxia-induced factor. Understanding the process of kidney damage during hypoxia can complement the concept of nephroprotection in patients with chronic kidney disease, will provide an opportunity to improve the guidelines on the management of this group of patients.
Authors and Affiliations
O. Yu. Lysianska
Keywords
Related Articles
- EP ID EP208414
- DOI -
- Views 44
- Downloads 0
Possibilities of 4-Component Therapy in Renal Protection: UNIKUM Trial Results
.
Immunobiological drugs in the treatment of rheumatic diseases
Rheumatic diseases (RD) are among the most common chronic diseases of the musculoskeletal system and connective tissue which are found in both adults and children. The cause of these pathological conditions can be change...
Effect of Herbal Preparation Canephron® N on the Course of Diabetic Nephropathy in Patients with Diabetes Mellitus Type 2: Results of a Comparative Cohort Study
The Objective of the Study. Diabetic nephropathy (DN) is a severe and common complication of diabetes mellitus, leading to end-stage renal failure in 30 % of patients with diabetes mellitus. The first manifestation of DN...
Hypomagnesemia in Chronic Kidney Disease: Problem or Individual Characteristics of Certain Patients?
The article considers the problem of magnesium deficiency in patients with chronic kidney disease. It requires special attention from clinicians due to the increased risk of cardiovascular complications. The study reveal...
Influence of Aflazin® on the Adhesive Properties of Microorganisms — Pathogens of Catheter-Related Infections
The influence of Aflazin® (UTIRose™) and separately its combination with levofloxacin on the adhesive properties of opportunistic pathogens has been studied. It is found that addition of the active substance of Aflazin®...